Researcher
Robert Colebunders
- Research Expertise:Training and providing advice in the field of infectious diseases, tropical medicine, travel medicine and HIV infection and assistance in establishing national treatment guidelines in these domains.
- Keywords:TUBERCULOSIS, INFECTIOUS DISEASES, HAEMORRAGHIC FEVER, HIV-INFECTION, TROPICAL DISEASE, Medicine
- Disciplines:Immunology, Tropical medicine, Microbiology
- Research techniques:Treatment guidelines.
- Users of research expertise:- Physicians - Medical students - Clinical researchers - Ministry of Health
Affiliations
- Global Health Institute (GHI) (Research group)
Member
From1 Jan 2019 → Today - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Oct 2014 → 31 Dec 2018 - Epidemiology and social medicine (ESOC) (Research group)
Member
From1 Oct 2003 → 30 Sep 2014
Projects
1 - 10 of 11
- Reducing onchocerciasis-associated morbidity in children.From1 Nov 2022 → TodayFunding: FWO junior postdoctoral fellowship
- Project in the field of Onchocerciasis diagnosis.From1 Jun 2022 → TodayFunding: Foreign foundations, funds with scientific view
- Stopping the burden of disease caused by onchocerciasis-associated epilepsy.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- The assessment of psycho-social and behavioral response and compliance to restriction measures to prevent and control of Covid-19: an series of rapid surveys.From21 Jan 2021 → 20 Jan 2024Funding: Foreign public sponsor
- Effective information exchange and care orientation in Covid-19-related contact tracing phone calls. An applied sociolinguistic and conversation analytic enquiry into optimizing interactional dynamics and pragmatic awareness.From1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects
- African network to study, treat and prevent onchocerciasis associated epilepsy (OAE-Africa).From1 Jan 2019 → 31 Aug 2022Funding: VLIR-UOS Joint
- Multi-disciplinary approach to control onchocersiasis-associated epilepsy in the Mahenge area in Morogoro region, Tanzania.From1 Jan 2018 → 31 Aug 2022Funding: VLIR-UOS TEAM
- Development of a policy to stop the suffering caused by Nodding Syndrome and Onchocerciasis associated epilepsy (NSstop).From1 Sep 2017 → 28 Feb 2019Funding: H2020 - Frontier Research (ERC)
- Nodding Syndrome: a trans-disciplinary approach to identify the cause and decrease the incidence of river epilepsy (NSETHIO).From1 Oct 2015 → 30 Nov 2021Funding: H2020 - Frontier Research (ERC)
- An investigation into the geographical distribution, host species, burden of disease and optimal diagnosis and treatment of Emmonsia hoerikwaggiana infections.From1 Jan 2014 → 31 Dec 2017Funding: FWO research project
Publications
31 - 40 of 310
- Community perception of epilepsy and its treatment in onchocerciasis-endemic villages of Maridi county, western equatoria state, South Sudan(2022)
Authors: Stephen Raimon Jada, Moses Samuel Tionga, Joseph Nelson Siewe Fodjo, Jane Y. Carter, Makoi Yibi Logora, Robert Colebunders
- Adults' acceptance of COVID-19 vaccine for children in selected lower- and middle-income countries(2022)
Authors: Suzanna Awang Bono, Ching Sin Siau, Won Sun Chen, Wah Yun Low, Edlaine Faria de Moura Villela, Supa Pengpid, M. Tasdik Hasan, Philippe Sessou, John D. Ditekemena, Bob Omoda Amodan, et al.
- Adherence to COVID-19 preventive measures among dental care workers in Vietnam(2022)
Authors: Tai Tan Tran, Thang Van Vo, Tuyen Dinh Hoang, Minh Vu Hoang, Nhu Thi Quynh Tran, Robert Colebunders
- From nodding syndrome to onchocerciasis associated epilepsy(2022)
Authors: Nolbert Gumisiriza, Robert Colebunders
Number of pages: 156 - Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic(2022)
Authors: Leonard Ngarka, Joseph Nelson Siewe Fodjo, Wepnyu Yembe Njamnshi, John D.D. Ditekemena, Mohammed A.M. Ahmed, Rhoda K.K. Wanyenze, Janet Dula, Philippe Sessou, Christian T.T. Happi, John N.N. Nkengasong, et al.
Pages: 1 - 11 - Psychosocial factors associated with adherence to COVID-19 preventive measures in low-middle-income countries, December 2020 to February 2021(2022)
Authors: Supa Pengpid, Karl Peltzer, Chutarat Sathirapanya, Phanthanee Thitichai, Edlaine Faria Moura de Villela, Tamara Rodrigues Zanuzzi, Felipe Andrade de Bandeira, Suzanna A. Bono, Ching Sin Siau, Won Sun Chen, et al.
Pages: 1 - 11 - Defining post-COVID condition(2022)
Authors: Juan Carlos Villar, Nolbert Gumisiriza, Lucas Guimaraes Abreu, Richard J. Maude, Robert Colebunders
Pages: 316 - 317 - Immunoinformatics design and assessment of a multiepitope antigen (OvMCBL02) for onchocerciasis diagnosis and monitoring(2022)
Authors: Bernis Neneyoh Yengo, Cabirou Mounchili Shintouo, An Hotterbeekx, Ntang Emmaculate Yaah, Robert Adamu Shey, Quanico, Geert Baggerman, Lawrence Ayong, Luc Vanhamme, Rose NJEMINI, et al.
Pages: 1 - 15 - High COVID-19 vaccine acceptance among eye healthcare workers in Uganda(2022)
Authors: Juliet Otiti-Sengeri, Omaido Blair Andrew, Rebecca Claire Lusobya, Immaculate Atukunda, Caroline Nalukenge, Abubakar Kalinaki, John Mukisa, Damalie Nakanjako, Robert Colebunders
Pages: 1 - 10 - Community knowledge, attitudes, and practices regarding epilepsy in Mahenge, Tanzania(2022)
Authors: Bruno P. Mmbando, Dan K. Bhwana, Isolide S. Massawe, Pendo Magili, Sloan Mahone, Williams Makunde, Adiel K. Mushi, Robert Colebunders
Linked dataset
1 - 2 of 2
- Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy : a randomized proof-of-concept clinical trial (Creator)
- Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy treated with phenobarbital: a randomized clinical trial in the Democratic Republic of Congo (Creator)